APPENDIX 2

Public Hearing

Tuesday, 09 November 2010
Parliament House, Canberra

Committee Members in attendance
Senator Claire Moore (Chair)
Senator Rachel Siewert (Deputy Chair)
Senator Carol Brown
Senator Sue Boyce
Senator Concetta Fierravanti-Wells
Senator Russell Trood

Witnesses

Generic Medicines Industry Association Pty Ltd
Dr Martin Cross, Chairman
Mr Robert Ellis, Board Member
Mr Roger Millichamp, Board Member
Ms Kate Lynch, Chief Executive Officer

The Pharmacy Guild of Australia
Ms Toni Riley, Chair
Mr Stephen Armstrong, National Manager, Economic Analysis and e-Health

Medicines Australia
Mr William Louis Delaat, Chairman
Ms Jane Orr, Managing Director MSD Australia and New Zealand
Mr Peter Vermeer, Director Corporate Affairs and Market Access, Eli Lilly Australia
Ms Deborah Waterhouse, General Manager GlaxoSmithKline Australia and New Zealand
Dr Brendan Shaw, Chief Executive Officer

Consumers Health Forum of Australia
Ms Carol Bennett, Executive Director
Ms Anna Wise, Senior Policy Manager  

National Pharmaceutical Services Association
Mr Patrick Davies, President
Mr Brett Lucas Barons, Director
Mr Mark Robert Hooper, Director
Ms Pattie Anne Beerens, Executive Director

Department of Health and Ageing
Mr David Learmonth, Deputy Secretary
Mr Andrew Stuart, Acting Deputy Secretary
Ms Adriana Platona, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division
Mr Nick Henderson, Acting Assistant Secretary, Policy and Analysis Branch, Pharmaceutical Benefits Division
Mr Kim Bessell, Principal Pharmacy Adviser, Pharmaceutical Benefits Division 

Navigation: Previous Page | Contents